Seventy-three cases of severe herpes zoster infection admitted to a regional infectious disease unit over a 3-year period were teviewed. Complications were common. Elderly patients were in the majority (55%), were hospitalized for longer and accounted for 78% of all complications. Acyclovir therapy was used in 44 cases with a reduction in both the duration of hospital stay and complication rate.
Introduction
Minor infections with herpes zoster (HZ) are common, usually self limiting and resolve with few if any problems. Severe disease can occur but is rare. The initial care of patients with severe HZ is by the attending physician and thus the majority of doctors see relatively few such cases and are unable to obtain a full picture of the disease spectrum. The pattern of disease in the community has recently been studied in the USA1 but no recent information is available on the pattern or complications ofthe disease in the UK.
In West Yorkshire, cases of severe HZ are treated in the regional infectious diseases unit allowing assessment of subjects from a defined catchment area. The present study investigated the mode of referral, range of complications and outcome of patients with HZ admitted to this unit.
Methods
Seacroft Hospital is a regional infectious disease unit covering Leeds and the surrounding district, total catchment area 1200 000. Patients of all ages are referred directly to the unit by the attending physician, either the general practitioner, the hospital doctor or, rarely, the community health services. All diagnoses are recorded on a central computerized system. All admissions during the period were analysed for diagnosis, duration of hospital stay and complications ofthe disease. All cases included in the study had HZ infection proven by a suitable clinical presentation and either paired serological studies of HZ antibody production (a 4-fold rise in complement fixation titre being diagnostic), direct examination of vesicular fluid for viral particles or direct viral culture of vesicular fluid.
Results
During the study period, 73 patients were admitted with proven HZ infection. Mean age 59.1 years (range 8-91 years), with 40 subjects over 65-years-old. Thirtyseven subjects were admitted directly from the GP, 36 subjects via other hospital services. The anatomical distribution of the lesions was, facial 38 cases with eye involvement in 19 cases, trunk 35 cases (Table 1) . Involvement of more than one dermatome was seen in 8 cases and disseminated disease in 3 cases. Underlying causes were found in 13 cases; 11 subjects (7 elderly) had malignant disease, of whom 4 were neutropenic due to chemotherapy, and 2 subjects were on high dose prednisolone for chronic airways disease.
The mean hospital stay was 9 days, 12.1 days in the elderly. The main determinant of length of hospital stay and complication rate was the time of referral from time of initial diagnosis ( Table 2) .
Complications were common, often severe and were commoner in the elderly. Post herpetic neuralgia (mean follow-up time, 8 weeks) was seen in 13 cases (9 elderly), the Ramsey Hunt syndrome in 5 cases (3 elderly), severe secondary sepsis in 13 cases (7 elderly No of complications 5 (71%) 12 (75%) Table 3 .
The study is not a formal evaluation of acyclovir treatment but early referral allowed early treatment with acyclovir and a reduction in complications.
Complications were commoner in the -elderly and usually more severe.
Discussion
Herpes zoster is common with an annual incidence of 1.4-3.4 cases per 10001=3. In the present study we cannot claim that all cases ofsevere HZ were admitted to the unit but we believe the majority of such cases are included giving an annual itinidence of 1.9 per 100 000. This is the first study on severe herpes zoster in the UK and the first performed-whilst effective antiviral therapy is available. The pattern of disease referred to the unit differs from that reported in studies in the USAi and Hong Kong4.-We noted a cranial nerve involvement in 60% of our subjects, higher than the 35-40% seen-in other studies. This probably reflects the severity ofthe cases referred to the unit, however a differing pattern ofdisease in the UK cannot be excluded. Inevitably complication rates in the hospital based samples are higher than those seen in community based studies. In the Rochester community study' post herpetic neuralgia occurred in 9% of subjects, ocular inotlvement in 2% of subjects and facial nerve involvement in 1% of subjects; comparative incidence rates in the current study are 29%, 11% and 8%, respectively.
The present work emphasizes the two main risk factors for severe herpes zoster, immunosuppression (either directly tumour-related or secondary to chemotherapy) and old age. ComplicAtions were commoner in the elderly and usually more severe. The relationship between severe infection and high dose steroid therapy is well known5'6 and was seen in 2 cases. Chemotherapy-related neutropenia was a precipitant fhator in 4 cases, but in 8-cases underlying malignant disease (usually haematological) was the major risk factor5'7.
The incidence of severe herpes zoster is reported to increase with age and this is confirmed in the current study.'The b1derly show decline in immune competence with age with both a reduced cellular immune response to varicella zoster and a decline in the humoral response being reported8'9. The former is thought to be more important for it is the cellular immune response which is essential for the limitation of the spread of the virus and for it's effective elimination. In our study, not only are the elderly more likely to be severely infected but they suffer more complications with sepsis, neurological sequelae and post-herpetic neuralgia.
Traditionally, referral to a hospital was only required if isolation or control of secondary sepsis was needed but this is no longer the case since acylovir became available'0'1"'12. This study is not a formal evaluation ofacyclovir therapy but confirms the usefulness ofthis drug. The efficacy of acyclovir in mmocompromised subjects is well established. Our data also demonstrates that in the 'immune competent' subject, early treatment with acyclovir reduces both the complication rate and the length of hospital stay. Acyclovir therapy offers the potential of altering the disease process and this should alter referral patterns.
Herpes szoter is not a benign disease; active therapy may be required. If theprimary infection is extensive, associated with an underlying cause (such as immuno suppression or steroid treatment) or in the elderly then prompt treatment may limit the disease and its compIscations.
